Advances in genomics and cancer biology will alter the design of human cancer studies.
Critic At Large
Most Recent
Twenty-first century lab reports will include test results read by a new breed of pathologist.
A global R&D treaty could boost innovation and improve the health of the world’s poor—and rich.
Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.
Plant research remains grossly underfunded, despite the demand for increased crop production to support a growing population.
As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?
Low-dose antibiotics in animal feed fuel drug-resistance in human infectious diseases.
Advances in cell-culture technologies are paving the way to the complete elimination of animals from the laboratory.
Measuring how individual cells differ from each other will enhance the predictive power of biology.
Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.
Subjects
- culture
- disease/medicine
- funding
- opinion
- policy
- public health
- regulation
- science policy
- science publishing
- techniques
Sub Categories
- Bio Business
- Capsule Reviews
- Careers
- Contributors
- Critic At Large
- Editorial
- Features
- Foundations
- Lab Tools
- Modus Operandi
- Notebook
- Profile
- Reading Frames
- Scientist to Watch
- Speaking of Science
- The Literature
- Thought Experiment
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
